Investment Opportunities
Invest in the Future of Healthcare.
Vitalabs is building the next generation of advanced analytics — making cutting-edge technologies like genomics and proteomics available to more patients, clinics, and researchers. From our base in Sweden, we’re piloting a new kind of lab: one that combines scientific excellence with simplicity, speed, and scalability.
We’re addressing a growing global demand for personalized diagnostics, with a business model designed for international expansion. Our approach is lean, our team is expert, and our mission is urgent.
If you’re an investor looking to support transformative health tech with strong scientific foundations and global ambition — we’d love to hear from you.
Market Opportunity
A global shift toward precision health is creating massive demand for advanced analytics.
The global genomics and proteomics markets are projected to exceed $100 billion by 2030, driven by trends like personalized medicine, AI-driven research, and a growing need for earlier, faster, and more accurate diagnostics. Yet, access to these technologies remains limited — often centralized, complex, and cost-prohibitive.
That’s where Vitalabs comes in.
We’re addressing a clear gap: high-quality lab services that are accessible, fast, and clinically relevant. From small research labs to regional hospitals, stakeholders are actively seeking partners who can deliver actionable data without logistical friction.
Our initial pilot in Sweden is designed to prove what’s possible — a scalable model we can adapt and deploy internationally. With strong regulatory expertise, a growing partner network, and a deep understanding of both clinical and research markets, Vitalabs is uniquely positioned to seize this moment.
Let’s work together.
Interested in working together? Fill out some info and we will be in touch shortly! We can't wait to hear from you!